CRG EXECUTIVE Q&A: Joe Catanese, CEO, Calyxo

CRG’s Brian Englander sat down with Joe Catanese, CEO of Calyxo, to discuss the kidney stone market, his career, and how his team is working to change kidney stone treatment through its innovative technology, ultimately improving the quality of care for patients who suffer from kidney stones.

Share:

Headquartered in Pleasanton, California, Calyxo is a commercial-stage urology medical device company focused on transforming kidney stone removal procedures. The company, originally Kalera Medical, was formed in 2016 through IP licensed out of Massachusetts General Hospital. The company’s lead product, the CVAC Aspiration System, is a steerable vacuum used to aspirate stone fragments following the use of a laser during stone removal procedures. CVAC is the first steerable kidney stone removal system used during ureteroscopy procedures and received 510(k) clearance…

Unlock the Full Article

Share your email below to keep reading — it’s free.

Your information is secure. View our Privacy Policy.

More News

View all
...

CRG 2025 AGM: Video for the Mental Health Panel

This video is from the Mental Health panel hosted at CRG's 2025 Annual General Meeting. The discussion brought together voices at the forefront of behavioral health to explore emerging treatment approaches and the evolving landscape of mental healthcare delivery.
...

Breaking the Script: The Rise of Antidepressant Drugs

The opioid crisis exposed how well-intentioned care, shaped by misaligned incentives, can cause widespread harm. A similar pattern is now emerging with antidepressants.
...

CRG Fireside Chat: Politics & Healthcare with Mark McClellan

Luke Düster and Dr. Mark McClellan discuss the impact of the upcoming election on healthcare policy and investment. They highlight how election outcomes may shift legislative priorities and examine the role of private equity in healthcare.